Anti-inflammatories and Adolescent Schizophrenia

• Status: Unknown status
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

A double-blind controlled trial assessing the efficacy of anti-inflammatories on symptoms and cognition of adolescents with schizophrenia

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico
• Treatments: Anti-Inflammatory Agents; Celecoxib; Minocycline

Criteria

Inclusion Criteria:

• Diagnosis of schizophrenia or schizophreniform disorder.

• Patients in their first psychotic episode or previously diagnosed

• No specific pharmacological treatment (antipsychotic at therapeutic doses in regular doses) in the previous two weeks.

• Have a responsible parent or guardian.

Exclusion Criteria:

• Active infection

• Chronic somatic diseases, including autoimmune diseases

• Comorbidity with anorexia, substance use disorders

• Pregnancy

• Use of anti-inflammatory medications or antibiotics